Diabetes Care Cascade and Compliance with WHO Global Coverage Targets in Iran: Findings of STEPS Survey 2021-Reference-Cited by-同舟云学术

Diabetes Care Cascade and Compliance with WHO Global Coverage Targets in Iran: Findings of STEPS Survey 2021

Published:2023-04-14 Issue: Volume: Page:
ISSN:
Container-title:
language:
Short-container-title:

Author:

Azadnajafabad Sina¹,Ahmadi Naser¹,Rezaei Negar¹,Rashidi Mohammad-Mahdi¹,Moghaddam Sahar Saeedi¹,Mohammadi Esmaeil¹,Abbasi-Kangevari Mohsen¹,Naderian Mohammadreza¹,Ghasemi Erfan¹,Farzi Yosef¹,Kazemi Ameneh¹,Dilmaghani-Marand Arezou¹,Yoosefi Moein¹,Rezaei Shahabeddin²,Nasserinejad Maryam¹,Fattahi Nima³,Rezaei Nazila¹,Haghshenas Rosa¹,Mehr Elmira Foroutan¹,Koolaji Sogol¹,Razi Farideh⁴,Djalalinia Shirin⁵,Larijani Bagher⁶,Farzadfar Farshad¹

Affiliation:

1. Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran

2. Human Nutrition Program, Department of Human Sciences, The Ohio State University, Columbus, OH

3. Department of Internal Medicine, Yale School of Medicine, New Haven, CT

4. Metabolomics and Genomics Research Center, Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran

5. Development of Research and Technology Center, Deputy of Research and Technology, Ministry of Health and Medical Education, Tehran

6. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran

Abstract

Abstract This study aimed to investigate the diabetes mellitus (DM) and prediabetes epidemiology, care cascade, and compliance with global coverage targets. We recruited the results of the nationally representative Iran STEPS Survey 2021. Diabetes and prediabetes were two main outcomes. Diabetes awareness, treatment coverage, and glycemic control were calculated for all population with diabetes to investigate the care cascade. Four global coverage targets for diabetes developed by the World Health Organization were adopted to assess the DM diagnosis and control status. Among 18 119 participants, the national prevalence of DM and prediabetes were 14.2% (95% confidence interval: 13.4–14.9) and 24.8% (23.9–25.7), respectively. The prevalence of DM treatment coverage was 65.0% (62.4–67.7), while the prevalence of good (HbA1C < 7%) glycemic control was 28.0% (25.0–31.0) among all individuals with diabetes. DM diagnosis and statin use statics were close to global targets (73.3% vs 80%, and 50.1% vs 60%); however, good glycemic control and strict blood pressure control statistics, were much way behind the goals (36.7% vs 80%, and 28.5% vs 80%). A major proportion of the Iranian population are affected by DM and prediabetes, and glycemic control is poorly achieved, indicating a sub-optimal care for diabetes and comorbidities like hypertension.

Publisher

Research Square Platform LLC

Reference40 articles.

1. Lin, X. et al. Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025. Scientific reports 10, 14790, doi:10.1038/s41598-020-71908-9 (2020).

2. Trends in the incidence of diabetes mellitus: results from the Global Burden of Disease Study 2017 and implications for diabetes mellitus prevention;Liu J;BMC public health,2020

3. Global Economic Burden of Diabetes in Adults: Projections From 2015 to 2030;Bommer C;Diabetes care,2018

4. Perlman, D. C., Jordan, A. E. & Nash, D. Conceptualizing Care Continua: Lessons from HIV, Hepatitis C Virus, Tuberculosis and Implications for the Development of Improved Care and Prevention Continua. Frontiers in public health 4, 296, doi:10.3389/fpubh.2016.00296 (2016).

5. Evaluation of the Cascade of Diabetes Care in the United States, 2005–2016;Kazemian P;JAMA internal medicine,2019